000 01762cam a2200205 4500
001 1903044421
008 060821t2005 xxu||||| |||| 00| 0 eng d
020 _a1903044421
100 _aMuers, M.F.
245 4 _aThe effective management of lung cancer
250 _a3rd
260 _aLondon :
_bAesculapius,
_c2005
300 _a203 pp.
490 _aUK key advances in clinical practice series
505 _aGenetics of lung cancer - current thinking on the nature and assessment of genetic predisposition to the disease; Population screening for lung cancer using computed tomography; Fluorescence bronchoscopy as a tool for the detection of early malignancy and pre-invasive pulmonary lesions; The role of positron emission tomography using fluorodeoxyglucose in lung cancer; Extended resection and reconstructive surgery - a review of current strategies; Surgery in advanced lung cancer - should we or shouldn't we; Neoadjuvant chemotherapy for non-small-cell lung cancer; CHART to CHARTWEL with neoadjuvant chemotherapy; Evidence and opinion for medical intervention in early disease; Advanced lung cancer - evidence and opinion for medical intervention; Current science and opinion in the management of mesothelioma; New biological approaches for effective therapy of non-small-cell lung cancer; Lung cancer and the National Cancer Plan; Impact of lung cancer patient groups on the delivery of the clinical service - accumulated experience; Defining the role of the lung cancer nurse specialist and the multidisciplinary team in increasing the effectiveness of service delivery; Economic evaluation of advances in the management of lung cancer
650 _aLung Cancer
_913290
650 _aMesothelioma
700 _aO'Byrne, K
999 _c40493
_d40493